Testing effectiveness (Phase 2)WithdrawnNCT03004105
What this trial is testing
MEDI4736 With Selumetinib for KRAS Mutant Non-Small Cell Lung Cancer (NSCLC)
Who this might be right for
Malignant Neoplasm of Respiratory and Intrathoracic Organ CarcinomaAdvanced Lung CancerRecurrent Nonsmall Cell Lung Cancer
M.D. Anderson Cancer Center